Terumo Corporation
Terumo Corporation is a global medical technology company providing medical devices, pharmaceutical solutions, and life-science products across clinical care and bioprocessing. The company develops and supplies systems for blood and plasma collection, therapeutic apheresis, blood product processing, cell and gene therapy manufacturing automation, infusion devices, and associated IT and service ecosystems. It also operates manufacturing sites and provides development and production support for drug-and-device combination products.
Industries
Nr. of Employees
Very Large (1000+)
Terumo Corporation
Head office: Shibuya-ku, Tokyo, Japan
Products
Whole-blood collection systems and leukoreduction blood bags
Collection systems and blood bags designed for whole-blood donation workflows, including leukocyte-reduction filtration.
Apheresis and component-collection systems
Devices for component apheresis collection and therapeutic apheresis procedures using centrifugal separation.
Automated blood processing and preparation systems
Systems for automated separation, processing, and formulation of blood components to support blood-center manufacturing.
Plasma collection systems and support ecosystem
Source-plasma collection devices combined with center-support services and IT solutions for plasma collection operations.
Pathogen-reduction system for blood products
System intended to reduce or inactivate pathogens in collected blood products (availability limited by country-specific approvals).
Cell therapy manufacturing equipment (cell expansion and filling/finish)
Automated cell expansion platforms and filling/finishing systems designed to support scaled manufacture of cell and gene therapy products.
Whole-blood collection systems and leukoreduction blood bags
Collection systems and blood bags designed for whole-blood donation workflows, including leukocyte-reduction filtration.
Apheresis and component-collection systems
Devices for component apheresis collection and therapeutic apheresis procedures using centrifugal separation.
Automated blood processing and preparation systems
Systems for automated separation, processing, and formulation of blood components to support blood-center manufacturing.
Plasma collection systems and support ecosystem
Source-plasma collection devices combined with center-support services and IT solutions for plasma collection operations.
Pathogen-reduction system for blood products
System intended to reduce or inactivate pathogens in collected blood products (availability limited by country-specific approvals).
Cell therapy manufacturing equipment (cell expansion and filling/finish)
Automated cell expansion platforms and filling/finishing systems designed to support scaled manufacture of cell and gene therapy products.
Services
Support for development and manufacturing of drug-and-device combination products, including development partnerships and production support for pharmaceutical companies.
Deployment of automated collection, separation, and processing systems for blood and plasma centers combined with IT solutions to improve throughput and donor experience.
Support for development and manufacturing of drug-and-device combination products, including development partnerships and production support for pharmaceutical companies.
Deployment of automated collection, separation, and processing systems for blood and plasma centers combined with IT solutions to improve throughput and donor experience.
Expertise Areas
- Blood and cell therapy systems
- Apheresis and therapeutic apheresis
- Plasma collection and fractionation support
- Cell and gene therapy manufacturing automation
Key Technologies
- Apheresis (centrifugal blood separation)
- Automated blood component processing systems
- Plasma source-collection systems
- Pathogen-reduction systems for blood products
News & Updates
Announcement of completed acquisition of an organ-perfusion company, indicating expansion into organ preservation technologies.
Start of operation of a new manufacturing line for infusion formulations to enhance stable supply of intravenous solutions.
Announcement of launch of four smart infusion pump models, including RFID-compatible units intended to support clinical staff workflows.
Announcement that several product groups were recipients of Good Design Awards for 2025.
Launch of a patient-facing informational website on a surgical therapy and a dedicated telephone inquiry line to provide information about heart-failure treatment.
Announcement updating consolidated earnings forecast for the fiscal year.
Announcement of completed acquisition of an organ-perfusion company, indicating expansion into organ preservation technologies.
Start of operation of a new manufacturing line for infusion formulations to enhance stable supply of intravenous solutions.
Announcement of launch of four smart infusion pump models, including RFID-compatible units intended to support clinical staff workflows.
Announcement that several product groups were recipients of Good Design Awards for 2025.
Launch of a patient-facing informational website on a surgical therapy and a dedicated telephone inquiry line to provide information about heart-failure treatment.
Announcement updating consolidated earnings forecast for the fiscal year.